Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppression.
Castelao
A M
AM
Department of Nephrology, Hospital de Bellvitge Princeps d'Espanya, University of Barcelona.
Barberá
M J
MJ
Blanco
A
A
Fiol
C
C
Griñó
J M
JM
Bover
J
J
GilVernet
S
S
Andrés
E
E
Serón
D
D
Castiñeiras
M J
MJ
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001053:Apolipoproteins / Q000097:blood*; D002784:Cholesterol / Q000097:blood*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use*; D011507:Proteinuria; D012044:Regression Analysis; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
D000961:Antilymphocyte Serum; D001053:Apolipoproteins; D008074:Lipoproteins; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D011241:Prednisone